Newsmeme!
Discover News you didn't know existed
Medication Therapy
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Questions to Pharmacists Rise After Michael Jackson's Death
Published July 10, 2009, 6:20 am, KTVN Reno
THURSDAY, July 9 (HealthDay News) -- News reports about a possible link between pop star Michael Jackson's death and his alleged abuse of prescription drugs may have increased the public's concern about prescription medication overdose risks, suggests a survey of U.S. pharmacists.
Drug Manufacturer Receives Fast Track Designation From FDA
Published July 10, 2009, 6:19 am, Medical News Today
Pharmaceutical firm Biogen Idec announced that the American drug watchdog the Food and Drug Administration (FDA) has granted Fast Track designation for its multiple sclerosis (MS) drug PEGylated interferon beta-1a (BIIB017).
Death of East Bay girl leaves parents searching for answers
Published July 10, 2009, 6:18 am, Contra Costa Times
The multicolored baseball caps that were Emily's signature style grace the entryway table. A pair of yellow flip flops waits at the front door. But Emily Toy will never wear them again. Two weeks ago, the Antioch girl was laid to rest in a Lafayette cemetery.
Survey: Speech Therapy Helps, But People Who Stutter Suffer Discrimination
Published July 10, 2009, 6:17 am, Medical News Today
Four out of 10 adults who stutter have been denied a job or promotion and 82 percent of children who stutter have been bullied or teased, according to a new survey by the National Stuttering Association. People who stutter make up about 1 percent of the population. Results of the survey were announced today at the organization's national conference in Scottsdale, AZ.
Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal(R) Vet, a New Chemotherapeutic ...
Published July 10, 2009, 6:00 am, PR Newswire via Yahoo! Finance
Abbott and Oasmia Pharmaceutical have announced a multi-year agreement to market one of the first cancer medications for dogs. The chemotherapeutic agent, called Paccal® Vet , represents the first generation of treatments of its kind and is currently being studied to treat Grade II and Grade III canine mast cell tumors where curative surgery cannot be performed.
Mental health services slashed by Barbour veto
Published July 10, 2009, 5:55 am, The Clarksdale Press Register
Clarksdale’s Region I Mental Health Center received news July 1 that may literally cut it off at its knees and cause serious problems for the four counties its serves and its 3,000 mental health clients.
REMERON(R) Now Approved In Japan For The Treatment Of Depression In Adult Patients
Published July 10, 2009, 5:20 am, Medical News Today
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for REMERON(R) /Reflex(R) (mirtazapine)15 mg Tablets for the treatment of major depressive disorder.(1) The product was developed jointly with Meiji Seika Kabushiki Kaisha, Ltd.
Amylin Pharmaceuticals Announces Positive Results From Dose-Ranging Clinical Study Of Pramlintide/Metreleptin ...
Published July 10, 2009, 5:19 am, Medical News Today
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, in overweight and obese patients.
Inquiry Reveals Appalling Gaps In Care For Parkinson's
Published July 10, 2009, 4:18 am, Medical News Today
The All Party Parliamentary Group (APPG) for Parkinson's Disease has released a shocking new report that documents severe inequalities in access to Parkinson's services in the UK. More than 350 people with Parkinson's and health and social care organisations gave evidence to the Inquiry.
Potential Patient Safety Risks Among Methadone Maintenance Treatment Patients Identified By Researchers
Published July 10, 2009, 3:18 am, Medical News Today
Boston Medical Center (BMC) researchers have identified potential safety risks among methadone maintenance treatment (MMT) patients due to the quantity and accuracy of medical record documentation. Improved communication and coordination among substance use treatment and medical providers could mitigate and manage the potential adverse effects of methadone and interacting medications.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |